Elevated membrane attack complex in human choroid with high risk complement factor H genotypes

Experimental Eye Research

Volumn 93, Issue 4, 2011, Pages 565-567

  Mullins, Robert F ^a   Dewald, Aaron D ^a   Streb, Luan M ^a   Wang, Kai ^a   Kuehn, Markus H ^a   Stone, Edwin M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Choriocapillaris; Choroid; Complement; Macular degeneration

Indexed keywords

COMPLEMENT FACTOR H; COMPLEMENT MEMBRANE ATTACK COMPLEX; HISTIDINE; TYROSINE;

ALLELE; ARTICLE; CHOROID; CONTROLLED STUDY; DNA POLYMORPHISM; DONOR; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION;

AGED; CHOROID; COMPLEMENT FACTOR H; COMPLEMENT MEMBRANE ATTACK COMPLEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMANS; MACULAR DEGENERATION; POLYMORPHISM, SINGLE NUCLEOTIDE; TISSUE DONORS;

EID: 80055063162     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2011.06.015     Document Type: Article

References (19)

1. Abrera-Abeleda M., Nishimura C., Smith J., Sethi S., McRae J., Murphy B., Silvestri G., Skerka C., Józsi M., Zipfel P., et al. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). J. Med. Genet. 2006, 43:582-589.
2. Anderson D.H., Radeke M.J., Gallo N.B., Chapin E.A., Johnson P.T., Curletti C.R., Hancox L.S., Hu J., Ebright J.N., Malek G., et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog. Retin. Eye Res. 2010, 29(2):95-112.
3. Edwards A., Ritter R., Abel K., Manning A., Panhuysen C., Farrer L. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
4. Ethen C.M., Reilly C., Feng X., Olsen T.W., Ferrington D.A. The proteome of central and peripheral retina with progression of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2006, 47(6):2280-2290.
5. Gold B., Merriam J.E., Zernant J., Hancox L.S., Taiber A.J., Gehrs K., Cramer K., Neel J., Bergeron J., Barile G.R., et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 2006, 38(4):458-462.
6. Hageman G., Anderson D., Johnson L., Hancox L., Taiber A., Hardisty L., Hageman J., Stockman H., Borchardt J., Gehrs K., et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U S A 2005, 102:7227-7232.
7. Haines J., Hauser M., Schmidt S., Scott W., Olson L., Gallins P., Spencer K., Kwan S., Noureddine M., Gilbert J., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421.
8. Hecker L.A., Edwards A.O. Genetic control of complement activation in humans and age related macular degeneration. Adv. Exp. Med. Biol. 2011, 703:49-62.
9. Johnson P.T., Betts K.E., Radeke M.J., Hageman G.S., Anderson D.H., Johnson L.V. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc. Natl. Acad. Sci. U S A 2006, 103(46):17456-17461.
10. Klein R., Zeiss C., Chew E., Tsai J., Sackler R., Haynes C., Henning A., Sangiovanni J., Mane S., Mayne S., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
11. Maller J.B., Fagerness J.A., Reynolds R.C., Neale B.M., Daly M.J., Seddon J.M. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat. Genet. 2007, 39(10):1200-1201.
12. Mullins R.F., Johnson M.N., Faidley E.A., Skeie J.M., Huang J. Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2011, 52(3):1606-1612.
13. Nozaki M., Raisler B.J., Sakurai E., Sarma J.V., Barnum S.R., Lambris J.D., Chen Y., Zhang K., Ambati B.K., Baffi J.Z., et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc. Natl. Acad. Sci. U S A 2006.
14. Seth A., Cui J., To E., Kwee M., Matsubara J. Complement-associated deposits in the human retina. Invest. Ophthalmol. Vis. Sci. 2008, 49(2):743-750.
15. Sivaprasad S., Adewoyin T., Bailey T.A., Dandekar S.S., Jenkins S., Webster A.R., Chong N.V. Estimation of systemic complement C3 activity in age-related macular degeneration. Arch. Ophthalmol. 2007, 125(4):515-519.
16. Skeie J.M., Fingert J., Russell S., Stone E.M., Mullins R.F. Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells. Invest. Ophthalmol. Vis. Sci. 2010, 51:5336-5342.
17. Streitherg B., Röhmel J. Exact distributions for permutations and rank tests: an introduction to some recently published algorithms. Stat. Softw. Newsl. 1986, 12:10-17.
18. Yates J.R., Sepp T., Matharu B.K., Khan J.C., Thurlby D.A., Shahid H., Clayton D.G., Hayward C., Morgan J., Wright A.F., et al. Complement C3 variant and the risk of age-related macular degeneration. N. Engl. J. Med. 2007, 357(6):553-561.
19. Yehoshua Z., Rosenfeld P.J., Albini T.A. Current clinical trials in dry AMD and the definition of appropriate clinical outcome measures. Semin. Ophthalmol. 2011, 26(3):167-180.